Literature DB >> 12895671

6-methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS.

Mariel Marder1, Haydeé Viola, Cristina Wasowski, Sebastián Fernández, Jorge H Medina, Alejandro C Paladini.   

Abstract

Valerian is an ancient tranquillizing drug obtained from the underground organs of several Valeriana species. Its active principles were assumed to be terpenoids in the form of valepotriates and/or as components of the essential oil. However, unknown active compounds were not discarded and synergic effects were suspected. We have recently isolated 6-methylapigenin (MA) from Valeriana wallichii and proved that it is a benzodiazepine binding site (BDZ-bs) ligand [Planta Med. 68 (2002) 934]. The present paper is the first report of the presence of 2S(-)-hesperidin in valeriana and describes that it has sedative and sleep-enhancing properties. MA, in turn, was found to have anxiolytic properties and was able to potentiate the sleep-enhancing properties of hesperidin (HN).MA and HN are new members of the growing family of natural flavonoids with activity on the CNS, and their properties suggest that they are promising drug leads in the field.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12895671     DOI: 10.1016/s0091-3057(03)00121-7

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  30 in total

1.  Passiflora incarnata L. (Passionflower) extracts elicit GABA currents in hippocampal neurons in vitro, and show anxiogenic and anticonvulsant effects in vivo, varying with extraction method.

Authors:  S-M Elsas; D J Rossi; J Raber; G White; C-A Seeley; W L Gregory; C Mohr; T Pfankuch; A Soumyanath
Journal:  Phytomedicine       Date:  2010-04-10       Impact factor: 5.340

Review 2.  Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function.

Authors:  David O Kennedy; Emma L Wightman
Journal:  Adv Nutr       Date:  2011-01-10       Impact factor: 8.701

Review 3.  Management of anxiety and sleep disorders: role of complementary and alternative medicine and challenges of integration with conventional orthodox care.

Authors:  Martins Ekor; Oluyomi S Adeyemi; Chiagoziem A Otuechere
Journal:  Chin J Integr Med       Date:  2012-12-29       Impact factor: 1.978

4.  Hesperidin, a flavone glycoside, as mediator of neuronal survival.

Authors:  Jader Nones; Tania Cristina Leite de Sampaio E Spohr; Flávia Carvalho Alcantara Gomes
Journal:  Neurochem Res       Date:  2011-05-08       Impact factor: 3.996

5.  Neuroprotective properties of Valeriana officinalis extracts.

Authors:  João O Malva; Sandra Santos; Tice Macedo
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

6.  Anticonvulsant and anxiolytic-like effects of compounds isolated from Polygala sabulosa (Polygalaceae) in rodents: in vitro and in vivo interactions with benzodiazepine binding sites.

Authors:  Filipe Silveira Duarte; Mariel Marder; Alexandre Ademar Hoeller; Marcelo Duzzioni; Beatriz Garcia Mendes; Moacir Geraldo Pizzolatti; Thereza Christina Monteiro De Lima
Journal:  Psychopharmacology (Berl)       Date:  2007-12-22       Impact factor: 4.530

7.  Aqueous and Ethanolic Valeriana officinalis Extracts Change the Binding of Ligands to Glutamate Receptors.

Authors:  Lisa M Del Valle-Mojica; José M Cordero-Hernández; Giselle González-Medina; Igmeris Ramos-Vélez; Nairimer Berríos-Cartagena; Bianca A Torres-Hernández; José G Ortíz
Journal:  Evid Based Complement Alternat Med       Date:  2010-12-02       Impact factor: 2.629

8.  Anxiolytic-like effect of Shigyakusan extract with low side effects in mice.

Authors:  Machiko Tanaka; Tadaaki Satou; Kazuo Koike
Journal:  J Nat Med       Date:  2013-02-02       Impact factor: 2.343

9.  The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects.

Authors:  Dominique Kavvadias; Philipp Sand; Kuresh A Youdim; M Zeeshan Qaiser; Catherine Rice-Evans; Roland Baur; Erwin Sigel; Wolf-Dieter Rausch; Peter Riederer; Peter Schreier
Journal:  Br J Pharmacol       Date:  2004-07       Impact factor: 8.739

10.  A randomized clinical trial of valerian fails to improve self-reported, polysomnographic, and actigraphic sleep in older women with insomnia.

Authors:  Diana M Taibi; Michael V Vitiello; Suzanne Barsness; Gary W Elmer; Gail D Anderson; Carol A Landis
Journal:  Sleep Med       Date:  2008-05-14       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.